The Nothing Phone 3a Lite recently made its debut in India as the newest member of the Phone 3a lineup. Positioned in the mid-range segment, the device comes from Carl Pei’s Nothing and is powered by ...

Nothing Phone 3a Lite, the latest entry in the Nothing 3 series, has stepped into an already crowded mid-range space at ₹20,999. And honestly, it’s a little hard to decode what Nothing is trying to ...

Honor Magic8 Lite is not exactly a lighter Magic8 or Magic8 Pro, despite what its model name might suggest. But it sure is shaping up like an excellent mid-range offer with an attractive design, ...

The Nothing Phone (3a) Lite shakes up the maker's entire portfolio - it's not only the first ever Lite phone, but it's also another take on Nothing's own CMF Phone 2 Pro. Once we thought the "a" ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise. Motorola's $180 Moto G Play for 2026 is getting some special ...

There is a definite air of gimmickry to this scope, but it's reasonably well-made and performed well in our tests. It may encourage younger users into the world of birdwatching and astronomy, and that ...

The Nothing Phone 3A Lite enters the highly competitive ₹20,000 smartphone market as the most affordable offering in Nothing’s lineup. Positioned below the Phone 3A and CMF Phone 2 Pro, it combines a ...

Verizon’s “Home Internet Lite” plan isn’t intended for everyone. But if your other internet options aren’t great, it seems like a solid new offering. Essentially, the new ‘Lite’ plan provides 5G home ...

OnePlus is known for its premium tablets, in addition to its smartphones. Recently, the brand made its entry into the affordable tablet segment with the launch of the OnePlus Pad Lite. The device is ...

The OnePlus Pad Lite is a tablet targeted at the sub-Rs 15,000 segment, and is focused more on content consumption than creation. The tablet boasts a good display, quad speakers, a clean interface, ...

An expert discusses how rilzabrutinib’s covalent reversible binding mechanism provides a favorable safety profile with only manageable grade 1 to 2 toxicities and no cardiovascular or bleeding ...